Frown lines, 11s or furrow lines – whatever you call them, the glabella lines that appear between the eyebrows are usually unwanted. The creases caused by scrunching your eyebrows can become etched in the skin, creating a grumpy appearance. If you have 11s you want gone, Botox® treatment is a very effective solution. We offer Botox for furrow lines treatment at pēkomd cosmetic surgery and rejuvenation center in Toledo, OH.
Furrow or frown lines was the first area approved for cosmetic treatment by Botox injections. While Botox had been used for many years for eye spasms and other medical uses, frown line treatment was the first FDA-approved cosmetic use. Botox is a neuromodulator that helps stop muscle contractions, which is why it works well for muscle spasms. It also can relax muscles that cause dynamic lines like the glabella furrows between the eyebrows.
Eliminate Frown Lines
The facial expressions you make require muscle movement that can put creases in the skin. As you get older, the skin loses its firmness and elasticity, which can result in permanent creases and lines. The glabella lines, or 11s, are very common and one of the first areas that show signs of aging. Botox can safely relax the muscle contractions that cause furrow or frown lines with a simple, fast treatment.
Botox injections for frown lines or other cosmetic uses only take about 20 minutes. You can come in on a lunch break and go back to work after your appointment. The effects of Botox take a few days to appear, usually within a week. The 11s will soften and disappear, staying gone for up to four months or longer. To maintain a smooth area between the brows, repeated Botox injections are needed every few months.
If you look cranky due to furrow lines between your eyebrows, soften those lines with Botox treatment. Contact us at pēkomd cosmetic surgery and rejuvenation center to schedule a Botox consultation or treatment at our clinic in Toledo, OH. Call today to book your appointment with our board-certified plastic surgeon, Dr. Peter Koltz.
